Latest News

Article ID: 717608

A new study from Washington University School of Medicine in St. Louis supports evidence that children with mild asthma can effectively manage the condition by using their two inhalers — one a steroid and the other a bronchodilator — when symptoms occur. This is in contrast to the traditional method of using the steroid daily, regardless of symptoms, and the bronchodilator when symptoms occur. The as-needed use of both inhalers is just as effective for mild asthma as the traditional protocol, according to the investigators.

Article ID: 717602

Electro-Active Technologies, Inc., of Knoxville, Tenn., has exclusively licensed two biorefinery technologies invented and patented by the startup’s co-founders while working at Oak Ridge National Laboratory. The technologies work as a system that converts organic waste into renewable hydrogen gas for use as a biofuel.

Article ID: 717601

Eating disorder researchers at The University of Texas Health Science Center at Houston (UTHealth) have discovered a neurocircuit in mice that, when activated, increased their stress levels while decreasing their desire to eat. Findings appear in Nature Communications.

Article ID: 717603

Kuwaiti dentist Alaa Al-Saffar, DDS, may be 7,000 miles from the Texas Medical Center but that did not keep her from catching a lecture on mouth ulcers at The University of Texas Health Science Center at Houston (UTHealth).

Article ID: 717600

Louise McCullough, MD, PhD, professor and chair of neurology at The University of Texas Health Science Center at Houston (UTHealth), has received the 2019 Landis Award for Outstanding Mentorship from the National Institute of Neurological Disorders and Stroke (NINDS).

Article ID: 717545

New research published this week in JAMA Oncology has found a lack of racial and ethnic diversity in clinical trials for cancer drugs. It raises concerns about the effectiveness of cancer drugs in some patients, especially since genetic differences may affect how a patient responds to a drug.